SANUWAVE Health (SNWV) analyst forecast and price target
Analyst forecast
Consensus of 1 analyst rating
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Roth Capital | Maintained | Buy | $47.00 from $53.00 | Mar 30, 2026 |
| Northland Capital Markets | Initiated Coverage | Outperform | $55.00 | Sep 3, 2025 |
| Roth Capital | Maintained | Buy | $55.00 from $54.00 | Aug 22, 2025 |
| Roth Capital | Initiated Coverage | Buy | $49.00 | Jul 29, 2025 |
Frequently asked questions
Is SNWV a buy, sell, or hold?
Analysts covering SANUWAVE Health currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on SNWV?
On Mar 30, 2026, Roth Capital maintained SANUWAVE Health at Buy with a price target of $47.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.